title: [Follow-up of newborns with hypoxic-ischaemic encephalopathy].
abstract: Hypothermia treatment for newborn infants with hypoxic-ischemic encephalopathy reduces the number of neonates who die or have permanent neurological deficits. Although this therapy is now standard of care, neonatal hypoxic-ischaemic encephalopathy still has a significant impact on the child's neurodevelopment and quality of life. Infants with hypoxic-ischaemic encephalopathy should be enrolled in multidisciplinary follow-up programs in order to detect impairments, to initiate early intervention, and to provide counselling and support for families. This article describes the main neurodevelopmental outcomes after term neonatal hypoxic-ischaemic encephalopathy. We offer recommendations for follow-up based on the infant's clinical condition and other prognostic indicators, mainly neonatal neuroimaging. Other aspects, such as palliative care and medico-legal issues, are also briefly discussed.
authors.affiliation: Department of Paediatrics, Hammersmith Hospital, Imperial College, Londres, Reino Unido. Electronic address: miriam.mbiarge@imperial.ac.uk.
authors.forename: M
authors.initials: M
authors.lastname: Martínez-Biarge
authors.affiliation: Servicio de Neonatología, Hospital Universitario Gregorio Marañón, Madrid, España.
authors.forename: D
authors.initials: D
authors.lastname: Blanco
authors.affiliation: Servicio de Neonatología, Hospital Sant Joan de Déu, Barcelona, España.
authors.forename: A
authors.initials: A
authors.lastname: García-Alix
authors.affiliation: Servicio de Neonatología, Hospital Universitario La Paz, Madrid, España.
authors.forename: S
authors.initials: S
authors.lastname: Salas
mesh_terms: D005500:Follow-Up Studies; D006801:Humans; D020925:Hypoxia-Ischemia, Brain / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D007231:Infant, Newborn; D012720:Severity of Illness Index
keywords: Cerebral palsy; Developmental outcomes; Encefalopatía hipóxico-isquémica; Follow-up program; Hipotermia; Hypothermia; Hypoxic-ischaemic encephalopathy; Neurodesarrollo; Parálisis cerebral; Seguimiento